• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yoshinami Tetsuhiro  吉波 哲大

ORCIDConnect your ORCID iD *help
Researcher Number 30894240
Other IDs
Affiliation (Current) 2025: 大阪大学, 医学部附属病院, 特任講師(常勤)
Affiliation (based on the past Project Information) *help 2021 – 2023: 大阪大学, 医学部附属病院, 特任助教(常勤)
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Except Principal Investigator
Basic Section 90140:Medical technology assessment-related
Keywords
Principal Investigator
再発リスク / residual cancer burden / MB-NGS / 乳癌 / risk of recurrence / non tumor-informed assay / Breast cancer / clinical implementation / breast cancer / ctDNA … More
Except Principal Investigator
… More データ品質 / 臨床研究データ / 自然言語処理解析 / クリニカルデータマネジメント / 品質評価 / リアルワールドデータ Less
  • Research Projects

    (2 results)
  • Research Products

    (2 results)
  • Co-Researchers

    (5 People)
  •  リアルワールドデータ品質評価指標の構築と信頼性向上のための対策

    • Principal Investigator
      山田 知美
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 90140:Medical technology assessment-related
    • Research Institution
      Osaka University
  •  Risk of distant recurrence based on ctDNA analysis by NGS platform with molucular barcodePrincipal Investigator

    • Principal Investigator
      Yoshinami Tetsuhiro
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Osaka University

All 2024 2023

All Presentation

  • [Presentation] 乳癌診断時の再発リスク評価目的でのctDNA検査におけるエピゲノム解析の有用性について2024

    • Author(s)
      吉波哲大
    • Organizer
      第23回日本乳癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-21K15591
  • [Presentation] Prospective study on eribulin efficacy in advanced and metastatic breast cancer:changes in TGF-β compared to other standard chemotherapy agents (KBCSG-TR 2018,POTENTIAL)2023

    • Author(s)
      Takahiro Nakayama, Tersuhiro Yoshinami, Yohei Uchida, Tomomi Yamada, Norikazu Masuda, et al.
    • Organizer
      San Antonio Breast Cancer Symposium
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K12885
  • 1.  山田 知美 (60363371)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 2.  武田 理宏 (70506493)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  中山 貴寛 (30527700)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 4.  倉上 弘幸 (20738421)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  山田 知明 (70898329)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi